Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darian Peters

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 14, 2025
Ro 64-6198, a selective NOP receptor agonist attenuates social impairments associated with NTG-induced migraine painAkanksha Mudgal, Olga Wronikowska-Denysiuk, Madeline Martinez, et al.
Biochemical Pharmacology|April 17, 2026
Ro 64-6198, a selective NOP receptor agonist blocks CGRP-induced migraine-like symptoms and modulates cellular activationAriana Perez, Diana Pietrzak-Mitura, Akanksha Mudgal, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 14, 2025
Ro 64-6198, a selective NOP receptor agonist attenuates social impairments associated with NTG-induced migraine painAkanksha Mudgal, Olga Wronikowska-Denysiuk, Madeline Martinez, et al.
Biochemical Pharmacology|April 17, 2026
Ro 64-6198, a selective NOP receptor agonist blocks CGRP-induced migraine-like symptoms and modulates cellular activationAriana Perez, Diana Pietrzak-Mitura, Akanksha Mudgal, et al.
Pageof 2